Newsworthy
Dr. Alex Khoruts shares the important role the microbiome plays in a patients recovery. As the director of the U’s Microbiota Therapeutics Program he talks about his hopes that a multidisciplinary center that facilitates all microbiome research will soon be a possibility at the U.
Drs. Amy Karger and Marc Jenkins provided factual information to The Wall Street Journal about antibody or serology tests—blood tests designed to detect who was previously infected with the new coronavirus and has developed antibodies to it.
Dr. Marc Jenkins is quoted in a USA Today story about scientists continuing to work on essential projects while socially distancing in the lab.
Ben Brian is the winner of the 2020 Rheumatology Future Physician Scientist Award.
Considered to be one of the countries high performing medical school, the University of Minnesota believes that promoting and rewarding a culture of excellence is key in maintaining high standards. One way of displaying specifically how we impact medicine is to showcase those who exemplify the mission. Dr. Marc Jenkins was showcased, in an interview about how he has sought and discovered answers about our world through science.
CFI director Dr. Marc Jenkins explains how the University of Minnesota and Mayo Clinic are close to unveiling antibody tests that can determine if people have already been infected by the coronavirus that causes COVID-19 and are no longer threats to get or spread the infection.
The Star Tribune's Christopher Snowbeck and CFI's Director Marc Jenkins talk about "a whole new approach to vaccines" using viral RNA instead of the way current vaccines are produced using a weakened or killed form of a virus to stimulate an immune system response that produces antibodies.
Two faculty members from the University of Minnesota Medical School received the 2019 Distinguished Lectureship Award on Wednesday, Nov. 14, at the Dean’s Distinguished Research Lectureship (DDRL). David Masopust, Ph.D., a professor in the Department of Microbiology and Immunology and in the Center for Immunology, and Melissa Geller, MD, MS, associate professor and division director for the Department of Obstetrics, Gynecology and Women's Health, were the two awardees recognized for their outstanding research.
The program project grant "Mechanisms of Peripheral Induction of T-cell Tolerance" is funded for another 5 years. This grant has been sponsored by NIH for the last 21 years and continues to support great research in CFI.
Under the direction of Dr. David Masopust, researchers in the Center for Immunology are working on an HIV vaccine.